Senior insider sale
Chief Business Officer at KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC — senior position signals high conviction
$5.35M
67.06K shares
What this filing means
TESSARI EBEN plans to sell 67.06K shares of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC valued at approximately $5.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/29/2026ACC: 0001921094-26-000768
Officer· Chief Business Officer
Since Jun 2021
67.06K
Shares to sell
$5.35M
Approx. market value
67.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Employee Stock Option Exercise
Broker Payment for Cashless Exercise
7/29/2026
45.05KPSU / RSU - See Remarks
Equity Compensation
3/16/2022
22.01KTotal acquired67.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/29/2026 | Employee Stock Option Exercise Broker Payment for Cashless Exercise | 45.05K | — |
3/16/2022 | PSU / RSU - See Remarks Equity Compensation | 22.01K | — |
| Total | 67.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
67.06K
Market value
$5.35M
7/29/2026
Total
Units
67.06K
Value
$5.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/29/2026 | 67.06K | $5.35M | NASDAQ | Planned |
| Total | 67.06K | $5.35M | ||